Browse by author
Lookup NU author(s): Professor Andrew Pearson, Dr Robert Nelson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Intestinal dysmotility may be an important factor contributing to various gastrointestinal complications associated with cystic fibrosis. Motilin, enteroglucagon, neurotensin, and peptide YY may each play a role as endocrine hormones influencing gastrointestinal motor activity. Fasting children with cystic fibrosis (N = 8) and controls (N = 18) received a liquid nutrient test meal (fat 4 g/100 ml, protein 4 g/100 ml, carbohydrate 20 g/100 ml, 125 kcal/100 ml; 200 ml/m2) containing lactulose (5 g/100 ml), and the plasma concentrations of these peptides were studied. Mouth-to-cecum transit time was simultaneously studied using the breath H2 technique. Fasting levels of peptide YY and the postprandial response of all four peptides were significantly increased in those with cystic fibrosis. In repeat studies on those with cystic fibrosis after a period of altered pancreatic enzyme supplementation, no significant changes in peptide concentrations were observed. A rise in breath H2 permitting estimation of mouth-to-cecum transit time was noted in 17 control subjects (70-220 min, median 140). In contrast, a rise occurred in only two with cystic fibrosis after low-dose enzyme (70 and 180 min), and four after high-dose enzyme replacement (120-230 min, median 155). Altered gut hormone secretion may play a role in the pathophysiology of intestinal dysmotility in patients with cystic fibrosis.
Author(s): Murphy MS, Brunetto AL, Pearson ADJ, Ghatei MA, Nelson R, Eastham EJ, Bloom SR, Green AA
Publication type: Article
Publication status: Published
Journal: Digestive Diseases and Sciences
Year: 1992
Volume: 37
Issue: 2
Pages: 187-192
ISSN (print): 0163-2116
ISSN (electronic): 1573-2568
URL: http://dx.doi.org/10.1007/BF01308170
DOI: 10.1007/BF01308170
PubMed id: 1735334
Altmetrics provided by Altmetric
